Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Value
Increase
Decrease
Funds Holding
2,756
Funds Holding Change
+11
Funds Holding Growth
+0.4%
Value
$965B
Holding in Top 10
1,218
Top 10 Change
-6
Top 10 Growth
-0.5%
Value Growth
+3%
New
104
Increased
1,358
Reduced
1,151
Closed
65
Capital Inflow
$31.2B
Capital Outflow
$29.3B
Net Capital Flow
+$1.85B
Capital Flow Change
+$5.47B
Calls
$11.4B
Puts
$11.8B
Net Calls
-$444M
Put/Call Ratio
1.04